Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript March 12, 2025
Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $0.06, expectations were $0.05.
Operator: Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Instructions will be given at that time. As a reminder, this call...
